Clark Estates Inc. NY Lowers Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Clark Estates Inc. NY trimmed its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 7.4% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 371,250 shares of the company’s stock after selling 29,800 shares during the quarter. Clark Estates Inc. NY’s holdings in Definitive Healthcare were worth $1,659,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Glenmede Trust Co. NA raised its holdings in Definitive Healthcare by 41.1% in the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after purchasing an additional 5,362 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in shares of Definitive Healthcare in the 3rd quarter worth approximately $93,000. Algert Global LLC raised its stake in shares of Definitive Healthcare by 21.9% during the 3rd quarter. Algert Global LLC now owns 282,344 shares of the company’s stock worth $1,262,000 after acquiring an additional 50,700 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Definitive Healthcare by 5.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 436,132 shares of the company’s stock valued at $1,950,000 after acquiring an additional 23,706 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after acquiring an additional 1,626,813 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Performance

Shares of NASDAQ DH opened at $4.68 on Wednesday. The stock has a market cap of $540.63 million, a price-to-earnings ratio of -1.51, a PEG ratio of 3.28 and a beta of 1.33. Definitive Healthcare Corp. has a 12 month low of $3.19 and a 12 month high of $10.62. The company has a 50 day simple moving average of $4.35 and a two-hundred day simple moving average of $4.79. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on DH shares. JPMorgan Chase & Co. downgraded Definitive Healthcare from a “neutral” rating to an “underweight” rating and reduced their price target for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. Barclays dropped their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 7th. Morgan Stanley decreased their price target on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research note on Tuesday, August 6th. Robert W. Baird dropped their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Finally, BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $5.81.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.